Table 2. Prevalence of secondary drug resistance among previously treated tuberculosis patients, the Netherlands, 1993–2001*.
|
|
No. HIV negative (%)
(n = 294) |
No. HIV positive (%)
(n = 21) |
|---|---|---|
| Fully susceptible | 232 (78.9) | 15 (71.4) |
| Resistant to 1 drug:
Isoniazid
Rifampin
Streptomycin |
34 (11.9)
20 (6.8)
0
14 (4.8) |
4 (19.0)
2 (9.5)
2 (9.5)
0 |
| Resistant to 2 drugs |
17 (5.8) |
0 |
| Resistant to 3 drugs |
4 (1.4) |
0 |
| Resistant to 4 drugs |
7 (2.4) |
2 (9.5) |
| Any resistance |
62 (21.1) |
6 (28.6) |
| Any resistance to: |
|
|
| Isoniazid |
48 (16.3) |
4 (19.0) |
| Rifampin |
15 (5.1) |
4 (19.0)* |
| Streptomycin |
36 (12.2) |
2 (9.5) |
| Ethambutol |
9 (3.1) |
2 (9.5) |
| Multidrug resistance† | 15 (5.1) | 2 (9.5) |
*Undajusted odds ratio 4.12 (95% confidence interval 1.01–15.67, p = 0.036). †Resistant to at least isoniazid and rifampin.